2020 BIO Investor Forum Buzz of BIO Finalist
Amplified Sciences is a molecular diagnostics company unlike other diagnostics companies due to their ultra-sensitive molecular sensing technology with composition of matter IP exclusively licensed from Purdue University. The technology is disease state agnostic, can detect to the single molecule level, scales easily to point of care, and provides a very favorable cost structure for their platform of reagents. The first application – early detection of pancreatic cancer - is an assay that will quickly prove the investment thesis due to large unmet medical need and a favorable reimbursement path. The team has delivered a working prototype and published proof of concept data. $1.2M Seed round is open with $122k left to reach max oversubscription. Investors: Elevate Ventures, Golden Seeds, Indiana University Philanthropic VF, Purdue Ventures, Gravity Ventures, BeniVC, Houston Angel Network, St. Louis Arch Angels, Racine Medical Angels, Chemical Angel Network, IU Angels
Amplified Sciences is a molecular diagnostics company unlike other diagnostics companies due to their ultra-sensitive molecular sensing technology with composition of matter IP exclusively licensed from Purdue University. The technology is disease state agnostic, can detect to the single molecule level, scales easily to point of care, and provides a very favorable cost structure for their platform of reagents. The first application – early detection of pancreatic cancer - is an assay that will quickly prove the investment thesis due to large unmet medical need and a favorable reimbursement path. The team has delivered a working prototype and published proof of concept data. $1.2M Seed round is open with $122k left to reach max oversubscription. Investors: Elevate Ventures, Golden Seeds, Indiana University Philanthropic VF, Purdue Ventures, Gravity Ventures, BeniVC, Houston Angel Network, St. Louis Arch Angels, Racine Medical Angels, Chemical Angel Network, IU Angels
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Indiana
Company HQ Country:
United States
Year Founded:
2016
Main Therapeutic Focus:
Diagnostics
Lead Product in Development:
Diagnostic assay for early detection of pancreatic cancer
Development Phase of Primary Product:
Pre-Clinical
Number Of Unlicensed Products (For Which You Are Seeking Partners):
We have a suite of Composition of Matter IP exclusively licensed from Purdue tech transfer
Speaker
